Inside Indiana Business: New IBRI Study 'Essence of Big Data'


Inside Indiana Business reports:

"The Indiana Biosciences Research Institute in Indianapolis is bringing together several big industry names for a major study on how type 2 diabetes varies in different patients. Chief Executive Officer David Broecker says the "first-of-its-kind" partnership involves Eli Lilly and Co. (NYSE: LLY), Roche Diagnostics Corp., the Regenstrief Institute and Indiana University School of Medicine. He says the collaboration will give researchers access to information on more than 800,000 people with type 2 diabetes throughout Indiana." Read more.

2018 Annual Report cover

The IBRI 2018 Annual Report is now available. The report theme is “Discovery With Purpose,” which is also the IBRI’s motto as it reflects the Institute’s commitment to translating scientific discovery into improved outcomes for patients.